DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR IMIPENEM AND CILASTATIN

« Back to Dashboard

Clinical Trials for Imipenem And Cilastatin

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00080496	Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia	Completed	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3	To compare the efficacy and safety of the tigecycline regimen with that of the imipenem/cilastatin regimen in subjects with nosocomial pneumonia.
NCT00081744	Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects	Completed	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3	Purpose: To provide a mechanism for the emergency use of tigecycline in the appropriate clinical situations.
NCT00136201	Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections	Completed	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3	The primary objective of this study is to compare the safety and efficacy of an experimental antibiotic to a marketed antibiotic in the treatment of Chinese subjects with complicated intra-abdominal infections.
NCT00236834	A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization	Completed	PriCara, Unit of Ortho-McNeil, Inc.	Phase 3	The purpose of this study is to compare the safety and effectiveness of levofloxacin with imipenem/cilastatin in the treatment of hospital-acquired pneumonia

Clinical Trial Conditions for Imipenem And Cilastatin

Condition Name

Condition Name for Imipenem And Cilastatin
Intervention	Trials
Urinary Tract Infections	3
Complicated Urinary Tract Infection	2
Pneumonia, Bacterial	2
Abdominal Abscess	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Imipenem And Cilastatin
Intervention	Trials
Infection	16
Communicable Diseases	14
Pneumonia	7
Intraabdominal Infections	6

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Imipenem And Cilastatin

Trials by Country

Trials by Country for Imipenem And Cilastatin
Location	Trials
United States	49
China	29
France	6
Argentina	6
Brazil	6

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Imipenem And Cilastatin
Location	Trials
Ohio	4
California	4
Illinois	3
Iowa	2
Michigan	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Imipenem And Cilastatin

Clinical Trial Phase

Clinical Trial Phase for Imipenem And Cilastatin
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	11
Phase 2	7

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Imipenem And Cilastatin
Clinical Trial Phase	Trials
Completed	12
Recruiting	8
Terminated	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Imipenem And Cilastatin

Sponsor Name

Sponsor Name for Imipenem And Cilastatin
Sponsor	Trials
Merck Sharp & Dohme Corp.	10
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	3
Wyeth is now a wholly owned subsidiary of Pfizer	3

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Imipenem And Cilastatin
Sponsor	Trials
Industry	25
Other	10

Export unavailable in trial.
Subscribe for complete access.